Heramed Ltd
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the … Read more
Heramed Ltd (HMD) - Total Liabilities
Latest total liabilities as of June 2025: AU$658.25K AUD
Based on the latest financial reports, Heramed Ltd (HMD) has total liabilities worth AU$658.25K AUD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Heramed Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how Heramed Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Heramed Ltd Competitors by Total Liabilities
The table below lists competitors of Heramed Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ocumetics Technology Corp
OTCQB:OTCFF
|
USA | $5.52 Million |
|
Ananda Development Public Company Limited
BK:ANAN
|
Thailand | ฿17.27 Billion |
|
Wider Planet Inc.
KQ:321820
|
Korea | ₩37.12 Billion |
|
Intrusion Inc
NASDAQ:INTZ
|
USA | $3.86 Million |
|
Yung Zip Chemical Ind Co Ltd
TWO:4102
|
Taiwan | NT$261.24 Million |
|
I.Kloukinas-I.Lappas S.A
AT:KLM
|
Greece | €32.82 Million |
|
Advanced Credit Technologies Inc
PINK:CLOQ
|
USA | $30.36K |
Liability Composition Analysis (2016–2024)
This chart breaks down Heramed Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.04 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.74 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Heramed Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Heramed Ltd (2016–2024)
The table below shows the annual total liabilities of Heramed Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | AU$1.06 Million | -31.49% |
| 2023-12-31 | AU$1.55 Million | +19.51% |
| 2022-12-31 | AU$1.30 Million | -68.67% |
| 2021-12-31 | AU$4.13 Million | +247.71% |
| 2020-12-31 | AU$1.19 Million | -2.30% |
| 2019-12-31 | AU$1.22 Million | +32.78% |
| 2018-12-31 | AU$916.32K | -12.38% |
| 2017-12-31 | AU$1.05 Million | +22.28% |
| 2016-12-31 | AU$855.26K | -- |